Andreas Volk

Andreas Volk is a biochemist by training and did his PhD on HIV gene therapy in 2013 in Frankfurt, Germany. He then joined Octapharma as a scientist in the same year and worked in various positions in R&D and Quality departments. He obtained an MBA in 2015. Since late 2021 he is heading the Department for Virus and Prion Validation ensuring safety of Octapharma products from viral and prion contamination.